Pfizer, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion (49.6 billion pounds) in a move to diversify its revenue base. The world’s largest drugmaker, which raised $22.5 billion in debt from a consortium of banks to finance the deal,...
Read more